PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Trading Halt, page-219

  1. 3,791 Posts.
    lightbulb Created with Sketch. 1554
    All those missed deadlines sent the share price from above $3 to below $1. So yes I do know what that means, we raise at $1.30 as opposed to above $2, costing shareholders more dilution.

    PR’s track record on timelines and capital is poor. If you can’t admit that then you have blinkers on. I will concede he is doing well at dotting i’s and crossing t’s, which is equally important for a successful outcome.

    He’s just eating shareholder’s wealth by getting these other bits horribly wrong.
    Last edited by slura: 12/08/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.